Refractory Cancer Clinical Trials in Indianapolis, Indiana
2 recruitingIndianapolis, Indiana
Showing 1–2 of 2 trials
Recruiting
Phase 2
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
Refractory CancerRelapsed CancerLarge Cell Lymphoma, Diffuse
Dipenkumar Modi32 enrolled4 locationsNCT05852717
Recruiting
Phase 1Phase 2
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Solid Tumor, AdultCutaneous MelanomaRefractory Cancer+3 more
GV20 Therapeutics365 enrolled13 locationsNCT05669430